Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Carpaij (Groningen, Netherlands), F. Muntinghe (Groningen, Netherlands), M. Wagenaar (Groningen, Netherlands), J. Habing (Groningen, Netherlands), W. Timens (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands), L. Kunz (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), C. Holweg (South San Francisco, California, United States of America), W. Tew (South San Francisco, California, United States of America), M. Van Den Berge (Groningen, Netherlands). Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD. 962

Member's Comments

No comment yet.

Related content which might interest you: Serum periostin and eotaxin-2 as promising biomarkers in asthmatic smokers. Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Serum hyaluronate: A new biomarker of passive smoking-induced lung injury in asthmatic patients Source: Annual Congress 2010 - Innovations in the assessment of airway diseases Year: 2010 Visfatin as a possible serum biomarker in COPD Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Periostin is a systemic biomarker of eosinophilic airway inflammation in asthma Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001 Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020 Year: 2020 Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012